Patent ID: 11938181
Assignee: NFERENCE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 7:
8. A method for the identification and stratification of a subject at risk of SARS-CoV-2 infection comprising;
determining a plurality of demographic covariates of the subject, wherein
determining the plurality of demographic covariates comprises:
determining a propensity score for the subject; and
generating at least a negative cohort as a function of the propensity score;

identifying one or more vaccines not administered to the subject within the past 5 years, the one or more vaccines not having been administered to the subject within the past 5 years selected from a group comprising polio vaccine, an influenza vaccine, a varicella-zoster virus (VZV) vaccine, and a diphtheria-pertussis-tetanus vaccine using a logistic regression model as a function of the plurality of demographic covariates of the subject and the propensity score; and
if said subject is stratified into an at risk population and identified as not having received at least one of the one or more vaccines not administered to the subject within the past 5 years, administering to the subject at least one of the one or more vaccines not administered to the subject within the past 5 years.